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Abstract 
AIMS: This study aims to evaluate the ability of ChromID Carba agar, and Pseudomonas aeruginosa modified 
Hodge test (PAE-MHT) for detection of carbapenemase-producing P. aeruginosa and to determine the associated 
carbapenemase gene classes by PCR. 
METHODS: One hundred Carbapenem-resistant P. aeruginosa (CRPA) isolates were tested for: i) 
carbapenemases production by ChromID carba agar, Modified Hodge test (MHT) and (PAE-MHT) and ii) 
detection of some carbapenemase genes by PCR. 
RESULTS: All (100%) of the isolates showed growth on ChromID Carba agar with 100% sensitivity. Using MHT, 
54% of isolates were positive, 3% were indeterminate, and 43% were negative, demonstrating 58.9% sensitivity 
and 80% specificity. On performing PAE-MHT, 91% of the strains were positive, 3% were intermediate, and 6% 
were negative, demonstrating 97.9% sensitivity and 80% specificity. The most prevalent gene was blaKPC (81%), 
followed by blaVIM (74%); blaIMP was detected in only one isolate, and blaOXA-48 in 34% of the isolates. 
CONCLUSIONS: We conclude that PAE-MHT and ChromID Carba are sensitive, specific, simple and cost-
effective screening tests for detection of CRPA isolates compared to the traditional MHT. 
 
 
 
 
 
 
 
 
Introduction 
 
Carbapenemase-producing P. aeruginosa 
strains are resistant to almost all β-lactams. 
Carbapenem-resistant P. aeruginosa (CRPA) can be 
produced as a different consequence mechanism, 
such as decreased bacterial outer membrane 
permeability, overexpression of AmpCs or expression 
of carbapenemases [1]. 
Carbapenemases production in P. aeruginosa 
belong to the Ambler class A (KPC- and GES-type β- 
lactamases) and most commonly the Ambler class B 
(Metallo-β-lactamases) (MBLs) of the VIM, IMP, SPM, 
GIM, AIM, DIM, FIM, and NDM types [1], also OXA 
beta-lactamase genes in Pseudomonas aeruginosa 
have been identified [2]. 
Several inhibitor-based tests have been 
developed for the detection of carbapenemases in P. 
aeruginosa. However, misdetection of newly emerging 
isolates with a combination of carbapenemases could 
occur with these methods [3]. 
Using a novel indicator strain, K. pneumoniae 
ATCC 700603, the MHT was optimised for more 
accurate and reliable detection of carbapenemase 
production in P. aeruginosa, and this test was named 
the P. aeruginosa MHT (PAE-MHTs) [3]. Chromogenic 
media containing a carbapenem (chromID Carba, 
chromID KPC, chromID ESBL) are convenient tools 
for the screening and rapid detection of 
carbapenemase-producing Gram-negative bacilli 
(CPGNB). Among these media, chromID Carba 
demonstrated the highest sensitivity and specificity. 
Different genotypic methods have been applied for the 
detection of carbapenemases encoding genes in 
clinical isolates of P. aeuroginosa [4].  
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Thus, we performed ChromID Carba agar 
chromogenic medium, MHT and PAE-MHT to 
evaluate their ability for detection of CRPA and 
compared the results to PC. 
 
 
Methods 
 
The study included 100 carbapenem-resistant 
P. aeruginosa isolates (imipenem and/or meropenem) 
detected by disk diffusion method according to CLSI, 
2015 [5] among different isolates recovered from 
different specimens referred to Central Microbiology 
Laboratory for routine culture and sensitivity. The 
selected CRPA isolates had been referred from the 
following departments of Ain Shams University 
Hospitals; burn unit (55%), ICU (22%), surgery 
department (16%), and from the internal medicine 
department (7%). They were recovered from {pus 
(71%), respiratory (17 %), urine (11%) and only one 
strain (1%) from blood specimens. All isolates were 
subjected to: 
 
A) Phenotypic detection of 
carbapenemases producing P. aeruginosa 
 
1. ChromID carba agar 
After, overnight incubation of blood agar 
plates at 36 ± 1ºC, isolates were suspended in one 
mL of 0.9% sterile saline solution and the inoculum 
was adjusted to a density of a 0.5 McFarland standard 
(10
8
 CFU/ mL). Then, ten µL (10
6
 CFU/ mL) of this 
suspension was streaked by 10 µL standard loop onto 
ChromID Carba agar (bioMérieux, France). 
 
Figure 1: P. aeruginosa on ChromID Carba. Five strains are 
colourless, and five show brown pigmentation 
All plates were incubated in ambient air at 36 
± 1°C for 24 hours. Some carbapenemase producing 
Pseudomonas strains were colourless, and some 
showed brown pigmentation (Figure 1). Non-
carbapenemase producing Pseudomonas strains 
showed no growth [4]. 
 
2.  Modified Hodge test (MHT) 
Modified Hodge test was performed according 
to CLSI [6]. An inoculum of the indicator organisms (E. 
coli ATCC 25922), was adjusted to a 0.5 McFarland 
turbidity standard then a 1/10 dilution was made by 
adding 1ml of 0.5 McFarland turbidity tube to 9ml 
sterile saline and inoculated on the surfaces of 
Mueller-Hinton agar plates by swabbing. After the 
plates had been allowed to stand for 10 min at room 
temperature, a disk of meropenem, 10 µg (Oxoid, UK) 
was placed in the centre of each plate. Subsequently, 
four colonies of the test organisms, grown overnight 
on blood agar plate, were inoculated onto the plate in 
a straight line from the edge of the disk to the 
periphery of the plate (without touching the disc) by 
swabbing. A positive result is indicated by the 
enhanced growth of the indicator strain towards a 
meropenem disk, clover leaf-type indentation at the 
point of intersection of the isolate with the indicator 
strain. Whereas, no enhanced growth of the indicator 
strain towards a meropenem disk (no clover leaf-type 
indentation at the point of intersection of the isolate 
with the indicator strain is considered negative. 
Indeterminate results showed inhibition of the growth 
of the indicator strain produced by the test isolate 
(Figure 2 & 3). 
 
Figure 2: A) MHT; isolates 1, and 4 show positive results, isolates 2, 
and 3 show negative results; B) PAE-MHT; isolates 1, 2, 3, 4 show 
positive results 
 
3. Pseudomonas aeruginosa modified Hodge 
test (PAE-MHT) 
The same procedure as MHT was performed 
but K. pneumonia ATCC 700603 was used as 
indicator strain [7]. Interpretation of results was the 
same as in MHT (Figure 2 & 3). 
 
B) Genotypic detection of carbapenemase 
encoding genes 
All isolates were subjected to molecular 
identification of carbapenemase encoding genes 
using conventional PCR for (blaKPC) [8] and 
conventional multiplex PCR for (blaVIM, blaIMP, and 
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blaOXA-48) [9]. DNA extraction was done using 
Boiling method [10].  
 
Figure 3: A) MHT; isolates 1, 2 show indeterminate results, isolate 
3 shows a negative result, isolate 4 shows positive results; B) PAE-
MHT; isolates 1, 2 show indeterminate result, Isolate 3 shows a 
negative result, isolate 4 shows a positive result 
 
All PCR reactions were performed with My 
Taq HS Red mix (Bioline, UK) 2 X and carried out on 
a Thermal Cycler 2720 (Applied Biosystem, USA) 
instrument. The primers (Table 1) and the 
components of the master mix were added to templet 
DNA in a two separate reaction mixture; one for 
blaKPC gene and the other for blaIMP, blaVIM and 
blaOXA-48 genes in a final volume of 25 µL for each 
reaction mixture. 
Table 1: Primers sequences of carbapenemase encoding 
genes 
Primer name Primer sequence 
PCR product size 
(bp) 
Refrences 
KPC (forward) 
KPC (reverse) 
5′-ATGTCACTGTATCGCCGTCT-3′; 
5′-TTTTCAGAGCCTTACTGCCC-3′ 
893-bp [8] 
IMP-A (forward) 
IMP-B (reverse) 
5′-GAA GGY GTT TAT GTT CAT AC-3′ 
5′-GTA MGT TTC AAG AGT GATGC-3′ 
(where Y = C or T and M = A or C) 
587-bp [9] 
VIM2004A 
(forward) 
VIM2004B 
(reverse) 
5′-GTT TGG TCG CAT ATC GCA AC-3′ 
 
5′-AAT GCG CAG CAC CAG GATAG-3′ 
382-bp [9]) 
Oxa 48A (forward) 
Oxa 48B (reverse) 
5'-TTGGTGGCATCGATTATCGG-3′ 
5'- GAGCACTTCTTTTGTGATGGC-3' 
744-bp [31] 
Stock solution of primers = 100 pmol/1 µL; Working solution of primers = 4 pmol/1 µL. 
Stock solution of primers = 100 pmol/1 µL; Working solution of primers = 4 pmol/1 µL. 
 
The amplification program for blaKPC was 
composed of initial denaturation at 95°C for 15 min, 38 
cycles of denaturation for one minute at 94°C, 
annealing at 62°C for one minute, and an extension 
step at 72°C for one minute, then final extension for 
ten minutes at 72°C. As for blaIMP, blaVIM and 
blaOXA-48, it was composed of an initial denaturation 
step at 94°C for 5 min, followed by 30 cycles of DNA 
denaturation at 94°C for one minute, primer annealing 
at 54°C for one minute, and primer extension at 72°C 
for one and half minute. 
For detection of the amplified Products; ten µl 
were examined by 1.2% agarose gel in Tris-boric acid 
EDTA buffer (TBE). A DNA size marker was included 
for comparison. Electrophoresis was performed at 80 
volts, and the gel was then stained by ethidium 
bromide (0.5 µg/ml) for 30 minutes. Then, it is 
visualised using a UV transilluminator and 
photographed. BlaKPC, blaIMP, blaVIM, and blaOXA-
48 genes gave bands at 893, 587, 382, and 744 bp. 
Respectively (Figure 4). 
 
Figure 4: Gel electrophoresis of PCR products; Lane M is DNA 
ladder; Lanes 2, 4 & 5 are positive for KPC (893 bp); Lanes 6, 7, 9 
& 12 are positive for VIM (382 bp); Lane 8 is positive for IMP (587 
bp); Lane 10 is positive for for both oxa 48 (744 bp) with VIM 
(382bp); Lanes 1, 3, 11, 13 & 14 are negative 
 
 
Results 
 
All (100%) of the CRPA isolates showed 
growth on ChromID Carba agar after overnight 
incubation at 36 ± 1°C indicating carbapenemase 
production. Detection of carbapenemase by MHT 
showed that; (54%) of isolates were positive, three 
(3%) produced indeterminate results and (43%) were 
negative. On performing PAE-MHT, (91%) of the 
strains were positive, three (3%) produced 
indeterminate results and (6%) were negative. False 
positive results were 20%, and false negative results 
were 2.1%. 
Results of PCR for detection of the four 
carbapenemases encoding genes (blaKPC, blaVIM, 
blaIMP, blaOXA-48) on 100 CRPA isolates showed 
that; blaKPC, blaVIM, blaIMP and blaOXA-48 were 
detected in 81%, 74%, 1%, and 34% of the isolates 
respectively. The four carbapenemase genes were 
positive in (95%) of CRPA isolates. Five strains were 
negative for all the four carbapenemase genes 
included in the study. 
PCR results showed that 19% isolates were 
positive for only one gene; nine (%) isolates for 
blaKPC and ten (10%) isolates for blaVIM. Fifty seven 
(57%) strains were positive for two genes; blaKPC + 
blaVIM 41 (41%) strains, blaKPC + blaIMP one (1%) 
strain, blaKPC + blaOXA-48 11 (11%) strains and 
blaVIM + blaOXA-48 four (4%) strains. Nineteen 
strains (19%) were positive for three genes (blaKPC + 
blaVIM + blaOXA-48) collectively. No strains were 
positive for the four genes collectively (Table 2). 
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Table 2: The distribution of carbapenemase encoding genes 
among 95 PCR-positive isolates (Per isolate) 
Carbapenemase genes n (%) 
One gene only detected: 
KPC only 9 (9.5) 
VIM only 10 (10.5) 
Total 19 (20) 
Two genes detected: 
KPC + VIM 41 (43.2) 
KPC + IMP 1 (1) 
KPC + OXA-48 11 (11.6) 
VIM + OXA-48 4 (4.2) 
Total 57 (60) 
Three genes detected: 
KPC + VIM + OXA-48 19 (20)  
Total 19 (20  
 
In our study, the performances of MHT, PAE-
MHT and ChromID Carba were compared to PCR, 
which is recommended as a standard gold method for 
detection of carbapenemase production [11]. MHT 
gave 58.9% sensitivity, 80% specificity, 20% false 
positive rate and 41.1% false negative rate. On the 
other hand, PAE-MHT showed higher sensitivity 
(97.8%), specificity was 80%. 
When results of ChromID Carba were 
compared to PCR results, 95 strains, that were PCR 
positive, showed growth on the ChromID Carba. The 
remaining five isolates that showed growth on 
ChromID Carba were negative by PCR. Thus, the 
sensitivity of ChromID Carba was 100% (compared to 
PCR), but the specificity could not be calculated as 
the test didn’t show any negative results. 
Regarding the five isolates that were PCR 
negative but showed growth on the ChromID Carba, 
three of them gave positive results by both MHT and 
PAE-MHT while the remaining two were negative. 
In the present study, 3% of the CRPA isolates 
gave indeterminate results by both MHT and PAE-
MHT; 2% were only MBL producers (blaVIM), and 1% 
was both KPC and MBL (blaVIM) producer. 
 
 
Discussion 
 
Carbapenemase-producing P. aeruginosa 
strains are resistant to almost all β-Lactams. So, their 
spread in hospital settings is extremely dangerous. 
Also, carbapenemase genes are usually located on 
transferable genetic determinants such as plasmids, 
leading to their rapid dissemination. Hence, detection 
of carbapenemases is important for early 
implementation of infection control measures [1]. 
On performing MHT, 54% of our strains were 
positive, 3% of showed indeterminate result and 43% 
were negative. In a previous study, among the 32 
meropenem resistant P. aeruginosa, only 9 (28.1%) 
were positive for carbapenemases by MHT. However, 
16 (50.0%) were MBL producers by EDTA disk 
synergy test [12]. 
In our study, the sensitivity of MHT was 
58.95%, and specificity was 80%. False positive 
results were detected in 20% of the strains, and 
41.1% were a false negative. The false positive results 
might be due to the co-production of CTX-M and 
hyperproduction of AmpC which may result in the 
minor hydrolysis of carbapenems [13]. 
The false negative results might be related to 
the presence of NDM type of MBLs [11]. This was 
consistent with our results, where 4/10 (44%) strains 
carrying only MBL genes, gave negative result by 
MHT. Also, MHT does not distinguish between 
carbapenemase types and lack sensitivity for MBL 
detection unless it is performed on MacConkey’s agar 
or Zn
+2 added to the carbapenem disk [14]. Moreover, 
it noted that the sensitivity and specificity of the test 
for detecting low-level Metallo-β-lactamase production 
are not known, and no data exists on the usefulness 
of this test for the detection of carbapenemase 
production in non-fermenting gram-negative bacilli like 
Pseudomonas [5]. On the other hand, our study 
revealed that six out of nine strains carrying blaKPC 
(66%) were negative for MHT and all the eleven 
strains (100%) carrying both blaKPC and blaOXA-48 
were also negative for MHT. 
A study carried on 64 P. aeruginosa isolates 
(42 carbapenemase producers and 22 
carbapenemase non-producers) revealed that the 
MHT showed 78% sensitivity and 57% specificity. 
When the test was repeated on 15 strains, ten 
carbapenemase producers and five carbapenemase 
non-producers, nine strains out of 15 showed variable 
results over the test period (repeatability; 40%) [7]. 
In our study, 3% of the CRPA isolates 
produced indeterminate results by MHT; 2% were 
MBL producers (blaVIM), and 1% was both KPC and 
MBL (blaVIM) producer. This could be justified by a 
possible secretion of a substance such as colicin, a 
bacteriocin-peptide released by some GNB, which 
may inhibit the growth of the indicator strain and 
interfere with the results of the test [15]. 
Indeterminate results by MHT in 12% of MBL 
P. aeruginosa producers, which were not obtained for 
KPC producers, were observed in a previous study. 
Similarly, they reported a high proportion of 
indeterminate results (22% and 43% of 
carbapenemase and non- carbapenemase producers 
respectively) which occurred at a rate ten times higher 
in P. aeruginosa than that for Enterobacteriaceae. 
They optimised the MHT for more accurate and 
reliable detection of carbapenemase production in P. 
aeruginosa by using a novel indicator strain, K. 
pneumoniae ATCC 700603, and named this test the 
P. aeruginosa MHT (PAE-MHT). First, the test was 
performed using 64 P. aeruginosa isolates (42 
carbapenemase producers and 22 carbapenemase 
non-producers), and it demonstrated 100% sensitivity 
and 98% specificity for detection of carbapenemase 
activity without indeterminate results [7]. 
In the present study, 91% of the strains of 
CRPA isolates were positive by PAE-MHT, 3% 
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demonstrated indeterminate results and 6% were 
negative. The sensitivity of PAE-MHT was (97.81%), 
specificity was (80%), false positive results were 20%, 
and false negative results were 2.1%. 
The false positive results in our study might 
be explained as previously mentioned in MHT by the 
overproduction of cephalosporinases as AmpC 
enzymes or some ESBL enzymes as (CTM-X) that 
may have minor hydrolytic activity on 
carbapenemases [7], [13]. 
In the current study, two strains showed false 
negative results with PAE-MHT; one was carrying 
blaKPC only while the other was carrying both 
blaKPC and blaOXA-48. This may be explained by 
the possibility of failure of the phenotypic expression 
of these genes [16]. 
On performing PAE-MHT, 3% of our CRPA 
isolates showed indeterminate results which may be 
due to the production of substances by the tested 
isolates that inhibit the growth of the indicator strain as 
reported for MHT [17]. This was discordant with 
Pasteran et al., who reported no indeterminate results 
[7]. 
All of the (100) CRPA isolates, in our work, 
showed growth on ChromID Carba and 95% of 
isolates that were proved to carry carbapenemase 
genes by PCR showed growth on ChromID Carba, so 
the estimated sensitivity of the ChromID Carba was 
100%. However, the test showed false-positive results 
in five isolates that were negative by PCR. 
False positive results with ChromID Carba 
have different explanations. Simner et al. reported that 
growth on a chromogenic medium only signifies 
carbapenem resistance (e.g. AmpC producer with 
porin loss may grow) but does not confirm the 
production of a carbapenemase. In their study, 
ChromID Carba agar demonstrated 89.8% sensitivity 
in detecting carbapenemase producing GNB but still 
could grow carbapenemase negative GNB (included 
16.7 % of ESBL producers and 6.7% of AmpC 
producers) [4]. 
The second explanation could be the 
presence of other carbapenemase genes not included 
in our study as out of our five PCR negative isolates 
(positive by ChromID Carba), three strains were 
positive in both MHT and PAE-MHT, but the remaining 
two strains were negative by both tests. 
One limitation of the ChromID Carba agar 
which is mentioned by the manufacturer and several 
studies [18], [19], [20], is the limited detection of OXA-
48 producers, because of the low hydrolysing activity 
of this enzyme on carbapenem. However, in our 
study, this was not observed because all OXA-48 
producing strains showed growth on Chrom ID Carba. 
This could be attributed to the finding that all OXA-48 
isolates in our study were co-producer of other 
carbapenemases (KPC or VIM). 
Diene and Rolain reported that the VIM 
carbapenemases enzymes, composed of around 33 
variants, have been widely described in P.aeruginosa 
and lesser found in enterobacterial species [21].
 Carrër et al. reported that most 
carbapenemases in clinical isolates of GNB including 
P. aeruginosa are IMP/VIM and KPC [22]. 
Among our 100 CRPA isolates, 
carbapenemase genes (blaKPC, blaVIM, blaIMP, 
blaOXA-48) were detected in 95% of the isolates. 
Only five isolates produced negative results for all of 
these four carbapenemases. PCR results revealed 
that blaKPC was the most prevalent gene as it was 
detected in 81% of the isolates, followed by blaVIM 
which was detected in 74% of the isolates, blaOXA-48 
in 34% of the isolates, while blaIMP was found in one 
per cent of the isolates. Fifty seven (57%) of the 
strains was positive for two genes; (41%:
 blaKPC + blaVIM), (1%: blaKPC + blaIMP), 
(11%: blaKPC + blaOXA-48) and (4%: blaVIM + bla 
OXA-48). Nineteen strains (19%) were positive for 
three genes (blaKPC + blaVIM + blaOXA-48). 
The five isolates with negative PCR results 
may carry other carbapenemase genes not included in 
our study (as mentioned previously) or may be due to 
the presence of another mechanism of carbapenem 
resistance, e.g. efflux pump and porin loss [23]. 
Comparable to our results Pasteran et al., 
reported that in 74 carbapenemase-producing P. 
aeruginosa isolates, 36 (48.6%) isolates carried 
blaKPC, 21 (28.37%) blaVIM, 9%) blaIMP and 8 
(10.8%) carried blaSPM [3]. Huang et al. found that 
out of 135 Enterobacteriaceae isolates, 72 isolates 
(53%) were carbapenemase producers, and out of 
221 P. aeruginosa isolates, 55 (25%) isolates were 
carbapenemase producers confirmed by PCR. 
BlaOXA-48 carbapenemase was the predominant 
carbapenemase gene (82%) found in 
Enterobacteriaceae, while blaVIM gene was largely 
predominated (93%) in P. aeruginosa [20]. 
In contrast to our results, some studies 
reported that in Pseudomonas species, 
carbapenemases are mostly MBLs of VIM, IMP, SPM, 
GIM, AIM, DIM and NDM types and to lesser extent 
Ambler class A carbapenemases of the KPC and GES 
types [24], [25], [26]. 
Koutsogiannou et al. reported that all of MBL 
positive CRPA isolates (49 isolates) were carrying the 
blaVIM gene and were spread in all hospital wards, 
especially among the non-ICU patients [27]. 
Simner et al. found that out of 49 
carbapenemases producing GNB 
(Enterobacteriaceae, P. aeruginosa and 
Acinetobacter) 16 isolates carried the blaKPC gene 
(one P. aeruginosa), 12 carried the blaVIM gene (five 
P. aeruginosa), and four isolates carried blaIMP (one 
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P. aeruginosa). One of these GNB isolates (E. 
cloacae) carried both blaVIM and blaOXA-48 [4]. 
Previous studies revealed association of 
MBLs (VIM/IMP) with KPC (blaKPC + blaVIM and 
blaKPC + blaIMP) in certain CRPA clones (ST564) in 
different areas of the world, indicating that this clone is 
a successful, worldwide multidrug-resistant clone with 
the ability to acquire relevant carbapenemases [24], 
[28]. 
Peshattiwar and Peerapur reported that the 
percentage of MBL (detected by a phenotypic method; 
IMP-EDTA DDST) in the imipenem resistant P. 
aeruginosa isolates was 62.5%. They concluded that 
carbapenem resistance in P. aeruginosa is 
predominantly via MBL production [29]. A nearly 
comparable rate was noted by Noyal et al., that 
attributed 50% of imipenem resistant P. aeruginosa 
isolates to the production of MBL [12]. Upadhyay et al. 
reported a high prevalence of MBL 56 (46.6%) among 
120 AmpC producing isolates [30]. 
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